Posts Tagged ‘Switzerland’
TERAPET Announces Partnership With Anzai Medical in Japan
This collaboration represents an important milestone in TERAPET’s international growth strategy and reinforces the company’s mission to make particle therapy safer, smarter, and more adaptive through imaging-driven verification. Anzai Medical Co., Ltd., a leading provider of advanced medical technologies in Japan. Under this agreement, Anzai Medical will serve as Geneva-based medtech company TERAPET’s exclusive distributor in Japan, supporting the introduction and adoption of TERAPET’s flagship platform Qualyscan® in clinical particle therapy workflows at leading centers of excellence nationwide. This collaboration represents an important milestone in TERAPET’s international growth strategy and reinforces the…
Read MoreAcrotec appoints Didier Deltort as CEO
Microtech and Medtech company, Acrotec Group, has an new CEO. François Billig, CEO of the Acrotec Group (“Acrotec” or the “Group”), becomes non-executive Chairman. Didier Deltort, the new CEO, brings extensive international management experience in the fast-growing medical technology and additive manufacturing sectors as the Group enters a new phase of its development. Acrotec, a…
Read MoreThe Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read MoreProf. Bloch and Prof. Courtine New Breakthrough for SCI Patients
In a rare double publication in Nature and Nature Medicine, landmark studies led by Professor Grégoire Courtine (EPFL), Professor Jocelyne Bloch (CHUV and University of Lausanne), and Dr. Aaron Phillips (University of Calgary) describe the development of a targeted therapy to stabilize blood pressure in SCI patients. Working with EPFL spin-off ONWARD Medical, the team…
Read More4 Swiss Start-Ups join Tech4Eva
Tech4Eva, Switzerland’s first start-up acceleration programme dedicated to women’s health (FemTech), has kicked off its fifth edition with a record-breaking 195 applications from 42 countries. Among the 16 start-ups selected for this year’s 6-month program, four promising companies hail from Switzerland—further underscoring the country’s growing role in this dynamic sector. This year’s Swiss cohort includes:…
Read MoreSwiss Medical Network joins the Mayo Clinic Care Network
Swiss Medical Network (Vaud – Switzerland) and Mayo Clinic are proud to announce that seven clinics and centres of Swiss Medical Network have joined the Mayo Clinic Care Network, becoming the first healthcare provider in Western Europe to enter the collaboration. The agreement includes Clinique de Genolier, Privatklinik Bethanien in Zurich, Clinica Sant’Anna in Lugano…
Read MoreSwiss Biotech Sector Shows Strength and Growth in 2024
Despite a challenging global market environment, the Swiss biotech sector once again demonstrated strength and resilience in 2024, as detailed in the newly released 2025 Swiss Biotech Report presented on 5 May 2025 during the Swiss Biotech Days. Co-authored by the Swiss Biotech Association, EY, and eight partner organizations, the report offers a deep dive…
Read MoreMedical devices: Switzerland soon aligned with the FDA?
The Swiss government is working on a simplified validation procedure for medical devices that have already been authorised by the US FDA – involving private bodies in the assessment. During a session on 30 April 2025, the Federal Council has laid the groundwork for a wider supply of medical devices. The aim is…
Read MoreSOPHiA GENETICS Announces Two Million Patient Cases Analysed
SOPHiA GENETICS, a cloud-native software company based in canton of Vaud (Switzerland) and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analysed on the AI-powered analytics Platform SOPHiA DDM™. “When we announced one million profiles analysed in 2022, it was a landmark moment in the…
Read MoreArtiria Medical and Reverso Therapeutics Awarded at BIND – BioInnovation Day
250 key players of the Swiss Health Valley gathered at Campus Biotech Geneva on 1 April 2025 for the 10th edition of BIND-BioInnovation Day. 29 groundbreaking life sciences projects developed in Western Switzerland Academic Institutions pitched in front of the audience. Artiria Medical and Reverso Therapeutics won the Best Startup Award and the Best Academic…
Read More